Judi Bryant

Title: Judi Bryant: Innovator in Protein Kinase Inhibition

Introduction

Judi Bryant is a distinguished inventor based in Mill Valley, California, with a remarkable portfolio of 11 patents. Her innovative work primarily focuses on the development of pharmaceutical compounds that have significant implications in medical treatments.

Latest Patents

Among her most recent patents is a notable invention titled "Dihydropyridine Derivatives as Useful as Protein Kinase Inhibitors." This invention encompasses novel dihydropyridine derivatives demonstrated to exhibit protein tyrosine kinase inhibitory activity, with potential applications in treating c-Met-mediated diseases or conditions. Another of her groundbreaking patents involves "Plasma Carboxypeptidase B Inhibitors," where various compounds are identified as effective inhibitors of plasma carboxypeptidase B. This patent outlines pharmaceutical compositions containing these compounds, their use as antithrombotic agents, and methods for their synthesis.

Career Highlights

Judi has significantly contributed to the pharmaceutical industry through her work with reputable companies such as Schering Aktiengesellschaft and Bayer Intellectual Property GmbH. Her insights and expertise have been pivotal in advancing innovative solutions within the biopharmaceutical sector.

Collaborations

Throughout her career, Judi has collaborated with esteemed colleagues, including Shendong Yuan and Brad Owen Buckman. These partnerships have fostered a creative environment that enables the exploration and development of novel therapeutic options.

Conclusion

Judi Bryant's contributions to the field of pharmacology through her inventions and collaborations have established her as a prominent figure in innovation. Her research on protein kinase inhibitors and carboxypeptidase inhibitors continues to inspire advancements in medical treatments, showcasing the vital role of inventors in enhancing human health.